Stockscreener 앱 받기
5.60
14.75%
0.72
시간 외 거래:
5.48
-0.12
-2.14%
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - GuruFocus
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com
Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan
Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com
Harvard Bioscience (HBIO) director buys 21,000 shares on open market - Stock Titan
Layoff Watch: What are analysts price targets for Harvard Bioscience IncTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Insider Buying: John Duke Acquires 5,000 Shares of Harvard Biosc - GuruFocus
Harvard Bioscience CEO Duke buys $25k in shares - Investing.com
Harvard Bioscience (HBIO) CEO adds shares and holds major RSU awards - Stock Titan
Harvard Bioscience at KeyBanc Forum: Strategic Growth and Market Focus By Investing.com - Investing.com Canada
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning - TipRanks
Market Trends: Whats next for Harvard Bioscience Inc stockRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Harvard Bioscience provides investor presentation; FY25 results, FY26 guidance and strategic actions - TradingView
Harvard Bioscience (NASDAQ: HBIO) posts FY25 metrics and guides modest 2026 growth - Stock Titan
HBIO: Benchmark Raises Price Target to $6.00, Maintains Speculat - GuruFocus
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split By Investing.com - Investing.com South Africa
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split - Investing.com
How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations - Yahoo Finance
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com Nigeria
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus
Benchmark cuts Harvard Bioscience stock price target on NIH concerns By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high By Investing.com - Investing.com Canada
HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com
Harvard Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-03-13 - Seeking Alpha
Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: - GuruFocus
Harvard Bioscience, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Earnings Call Summary | Harvard Bioscience(HBIO.US) Q4 2025 Earnings Conference - 富途牛牛
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harvard Bioscience: Q4 Earnings Snapshot - Chron
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria
Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com UK
Harvard Bioscience Q4 & Annual Financial Results 2025News and Statistics - IndexBox
Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet
HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus
Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus
HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus
Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget
Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView
HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative
Harvard Bioscience Q4 revenue falls 3%, reports net loss - TradingView
Harvard Bioscience : Q4 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
BRIEF-Harvard Bioscience Q4 Revenue USD 23.735 Million - TradingView
Life science tools firm absorbs $48M hit, eyes 2026 growth - Stock Titan
0.06%
0.65%
자본화:
|
볼륨(24시간):